Stability of BRAF V600E mutation in metastatic melanoma: new insights for therapeutic success?

被引:0
作者
L Sigalotti
E Fratta
G Parisi
S Coral
M Maio
机构
[1] Cancer Bioimmunotherapy Unit,Department of Medical Oncology
[2] Centro di Riferimento Oncologico,Department of Oncology
[3] Istituto di Ricovero e Cura a Carattere Scientifico,undefined
[4] Medical Oncology and Immunotherapy,undefined
[5] University Hospital of Siena,undefined
[6] Istituto Toscano Tumori,undefined
来源
British Journal of Cancer | 2011年 / 105卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:327 / 328
页数:1
相关论文
共 40 条
[1]  
Flaherty KT(2010)Inhibition of mutated, activated BRAF in metastatic melanoma N Engl J Med 363 809-819
[2]  
Puzanov I(2011)Polyclonality of BRAF mutations in primary melanoma and the selection of mutant alleles during progression Br J Cancer 104 464-468
[3]  
Kim KB(2011)Prognostic and clinicopathologic associations of oncogenic BRAF in metastatic melanoma J Clin Oncol 29 1239-1246
[4]  
Ribas A(2011)Resistance to BRAF inhibition in melanomas N Engl J Med 364 772-774
[5]  
McArthur GA(2008)In melanocytic lesions the fraction of BRAF V600E alleles is associated with sun exposure but unrelated to ERK phosphorylation Mod Pathol 21 716-726
[6]  
Sosman JA(undefined)undefined undefined undefined undefined-undefined
[7]  
O’Dwyer PJ(undefined)undefined undefined undefined undefined-undefined
[8]  
Lee RJ(undefined)undefined undefined undefined undefined-undefined
[9]  
Grippo JF(undefined)undefined undefined undefined undefined-undefined
[10]  
Nolop K(undefined)undefined undefined undefined undefined-undefined